Please login to the form below

Not currently logged in
Email:
Password:

Alliance Pharma to buy Cambridge Labs

Alliance Pharma has signed a conditional agreement to buy Cambridge Laboratories' UK and Ireland-based businesses

Alliance Pharma has signed a conditional agreement to buy Cambridge Laboratories' UK and Ireland-based businesses for a base price of £14.3m in cash and shares.

The deal also includes the value of its inventory at the time of completion, expected on 22 February 2010, and an additional deferred contingent payment of £1.6m-£2.1m.

The acquisition includes 18 prescription products across a range of therapeutic areas including ImmuCyst, an immunotherapy for superficial bladder cancer; Gelclair, an oral gel for managing oral mucositis in chemotherapy patients; and procarbazine, a treatment for Hodgkin's Lymphoma.

Combined sales of ImmuCyst, Gelclair, and procarbazine represent 40 per cent of Cambridge Laboratories total sales in 2009. Sales for the three products have also been growing at a combined rate of about 18 per cent per annum over the last three years.

The £1.6m-£2.1m deferred contingent consideration will be payable if ImmuCyst's licence is extended beyond March 2012. The final amount will depend on its sales figures during 2010 and 2011.

9th February 2010

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
KVA

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....